CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-002543
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Bifunctional glutamate/proline--tRNA ligase 
Protein Synonyms/Alias
 Bifunctional aminoacyl-tRNA synthetase; Cell proliferation-inducing gene 32 protein; Glutamatyl-prolyl-tRNA synthetase; Glutamate--tRNA ligase; Glutamyl-tRNA synthetase; GluRS; Proline--tRNA ligase; Prolyl-tRNA synthetase 
Gene Name
 EPRS 
Gene Synonyms/Alias
 GLNS; PARS; QARS; QPRS; PIG32 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
139AAWQEQLKQKKAPVHubiquitination[1]
173KWDVSTTKARVAPEKubiquitination[2]
197LPGAEMGKVTVRFPPubiquitination[2]
229QHYQVNFKGKLIMRFubiquitination[3, 4, 5]
231YQVNFKGKLIMRFDDubiquitination[2]
243FDDTNPEKEKEDFEKacetylation[6, 7]
245DTNPEKEKEDFEKVIacetylation[7]
282TIMKYAEKLIQEGKAacetylation[6]
288EKLIQEGKAYVDDTPubiquitination[1, 2, 8, 9]
300DTPAEQMKAEREQRIacetylation[6, 7, 10, 11]
300DTPAEQMKAEREQRImalonylation[12]
370PHPRTGNKYNVYPTYubiquitination[2]
417IEALGIRKPYIWEYSacetylation[10, 11]
417IEALGIRKPYIWEYSubiquitination[2]
435LNNTVLSKRKLTWFVubiquitination[1, 2, 4, 5, 7]
472GMTVEGLKQFIAAQGubiquitination[1, 2, 4, 7, 8, 9]
497DKIWAFNKKVIDPVAacetylation[6, 7, 10, 11]
498KIWAFNKKVIDPVAPacetylation[7, 10]
512PRYVALLKKEVIPVNubiquitination[4]
528PEAQEEMKEVAKHPKacetylation[6]
535KEVAKHPKNPEVGLKacetylation[10, 11]
535KEVAKHPKNPEVGLKubiquitination[4, 5]
542KNPEVGLKPVWYSPKacetylation[10, 11]
542KNPEVGLKPVWYSPKubiquitination[2, 7]
599AKLNLENKDYKKTTKacetylation[6, 7]
637ITKPVLGKDEDFKQYacetylation[6, 10]
666PCLKDLKKGDIIQLQubiquitination[2, 7]
708YIPDGHTKEMPTSGSubiquitination[2]
782EDVDAAVKQLLSLKAacetylation[6]
782EDVDAAVKQLLSLKAubiquitination[4, 5]
788VKQLLSLKAEYKEKTacetylation[6, 7, 10, 11]
849AEKSPKAKINEAVECubiquitination[2, 7]
861VECLLSLKAQYKEKTacetylation[7]
861VECLLSLKAQYKEKTubiquitination[2, 4, 5]
902GLETPEAKVLFDKVAubiquitination[5]
943LQLKAQYKSLIGVEYubiquitination[4, 5]
961SATGAEDKDKKKKEKacetylation[6]
991GQRKDPSKNQGGGLSubiquitination[1]
1009AGEGQGPKKQTRLGLubiquitination[1, 7]
1010GEGQGPKKQTRLGLEubiquitination[2]
1070FFDAEIKKLGVENCYubiquitination[1]
1109AWVTRSGKTELAEPIubiquitination[1, 2, 9]
1132VMYPAYAKWVQSHRDubiquitination[2, 4, 7]
1143SHRDLPIKLNQWCNVubiquitination[2, 5, 7]
1156NVVRWEFKHPQPFLRacetylation[6, 7, 10]
1156NVVRWEFKHPQPFLRubiquitination[2]
1361KFNHWELKGVPIRLEubiquitination[1, 8]
1375EVGPRDMKSCQFVAVubiquitination[1, 2, 5, 7]
1389VRRDTGEKLTVAENEacetylation[6, 7]
1389VRRDTGEKLTVAENEubiquitination[1, 9]
1435NTMEDFQKILDSGKIubiquitination[4, 5]
1477GAPSMGAKSLCIPFKubiquitination[2]
1484KSLCIPFKPLCELQPubiquitination[2]
1503VCGKNPAKYYTLFGRacetylation[10, 11]
1503VCGKNPAKYYTLFGRubiquitination[4, 5]
Reference
 [1] Systematic and quantitative assessment of the ubiquitin-modified proteome.
 Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
 Mol Cell. 2011 Oct 21;44(2):325-40. [PMID: 21906983]
 [2] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
 Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
 Mol Cell Proteomics. 2013 Mar;12(3):825-31. [PMID: 23266961]
 [3] A data set of human endogenous protein ubiquitination sites.
 Shi Y, Chan DW, Jung SY, Malovannaya A, Wang Y, Qin J.
 Mol Cell Proteomics. 2011 May;10(5):M110.002089. [PMID: 20972266]
 [4] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.
 Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C.
 Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [PMID: 21890473]
 [5] Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.
 Povlsen LK, Beli P, Wagner SA, Poulsen SL, Sylvestersen KB, Poulsen JW, Nielsen ML, Bekker-Jensen S, Mailand N, Choudhary C.
 Nat Cell Biol. 2012 Oct;14(10):1089-98. [PMID: 23000965]
 [6] Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3.
 Sol EM, Wagner SA, Weinert BT, Kumar A, Kim HS, Deng CX, Choudhary C.
 PLoS One. 2012;7(12):e50545. [PMID: 23236377]
 [7] Integrated proteomic analysis of post-translational modifications by serial enrichment.
 Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA.
 Nat Methods. 2013 Jul;10(7):634-7. [PMID: 23749302]
 [8] Global identification of modular cullin-RING ligase substrates.
 Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, Yen HC, Elledge SJ.
 Cell. 2011 Oct 14;147(2):459-74. [PMID: 21963094]
 [9] Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization.
 Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW.
 Nature. 2013 Apr 18;496(7445):372-6. [PMID: 23503661]
 [10] Lysine acetylation targets protein complexes and co-regulates major cellular functions.
 Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M.
 Science. 2009 Aug 14;325(5942):834-40. [PMID: 19608861]
 [11] Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response.
 Beli P, Lukashchuk N, Wagner SA, Weinert BT, Olsen JV, Baskcomb L, Mann M, Jackson SP, Choudhary C.
 Mol Cell. 2012 Apr 27;46(2):212-25. [PMID: 22424773]
 [12] The first identification of lysine malonylation substrates and its regulatory enzyme.
 Peng C, Lu Z, Xie Z, Cheng Z, Chen Y, Tan M, Luo H, Zhang Y, He W, Yang K, Zwaans BM, Tishkoff D, Ho L, Lombard D, He TC, Dai J, Verdin E, Ye Y, Zhao Y.
 Mol Cell Proteomics. 2011 Dec;10(12):M111.012658. [PMID: 21908771
Functional Description
 Catalyzes the attachment of the cognate amino acid to the corresponding tRNA in a two-step reaction: the amino acid is first activated by ATP to form a covalent intermediate with AMP and is then transferred to the acceptor end of the cognate tRNA. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation and subsequent phosphorylation dissociates from the multisynthetase complex and assembles into the GAIT complex which binds to stem loop- containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation. 
Sequence Annotation
 DOMAIN 749 805 WHEP-TRS 1.
 DOMAIN 822 878 WHEP-TRS 2.
 DOMAIN 900 956 WHEP-TRS 3.
 NP_BIND 432 436 ATP (By similarity).
 REGION 164 759 Glutamate--tRNA ligase.
 REGION 760 956 3 X 57 AA approximate repeats.
 REGION 959 991 Charged.
 REGION 1007 1512 Proline--tRNA ligase.
 MOTIF 204 214 "HIGH" region.
 MOTIF 432 436 "KMSKS" region.
 BINDING 211 211 ATP (By similarity).
 BINDING 398 398 ATP (By similarity).
 MOD_RES 300 300 N6-acetyllysine; alternate.
 MOD_RES 300 300 N6-malonyllysine; alternate.
 MOD_RES 417 417 N6-acetyllysine.
 MOD_RES 498 498 N6-acetyllysine.
 MOD_RES 535 535 N6-acetyllysine.
 MOD_RES 542 542 N6-acetyllysine.
 MOD_RES 637 637 N6-acetyllysine.
 MOD_RES 788 788 N6-acetyllysine.
 MOD_RES 872 872 Phosphotyrosine.
 MOD_RES 882 882 Phosphoserine.
 MOD_RES 885 885 Phosphoserine.
 MOD_RES 886 886 Phosphoserine; by CDK5.
 MOD_RES 891 891 Phosphoserine.
 MOD_RES 898 898 Phosphothreonine.
 MOD_RES 999 999 Phosphoserine.
 MOD_RES 1000 1000 Phosphoserine.
 MOD_RES 1503 1503 N6-acetyllysine.  
Keyword
 3D-structure; Acetylation; Aminoacyl-tRNA synthetase; ATP-binding; Complete proteome; Cytoplasm; Ligase; Multifunctional enzyme; Nucleotide-binding; Phosphoprotein; Polymorphism; Protein biosynthesis; Reference proteome; Repeat; RNA-binding; Translation regulation. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 1512 AA 
Protein Sequence
MATLSLTVNS GDPPLGALLA VEHVKDDVSI SVEEGKENIL HVSENVIFTD VNSILRYLAR 60
VATTAGLYGS NLMEHTEIDH WLEFSATKLS SCDSFTSTIN ELNHCLSLRT YLVGNSLSLA 120
DLCVWATLKG NAAWQEQLKQ KKAPVHVKRW FGFLEAQQAF QSVGTKWDVS TTKARVAPEK 180
KQDVGKFVEL PGAEMGKVTV RFPPEASGYL HIGHAKAALL NQHYQVNFKG KLIMRFDDTN 240
PEKEKEDFEK VILEDVAMLH IKPDQFTYTS DHFETIMKYA EKLIQEGKAY VDDTPAEQMK 300
AEREQRIDSK HRKNPIEKNL QMWEEMKKGS QFGQSCCLRA KIDMSSNNGC MRDPTLYRCK 360
IQPHPRTGNK YNVYPTYDFA CPIVDSIEGV THALRTTEYH DRDEQFYWII EALGIRKPYI 420
WEYSRLNLNN TVLSKRKLTW FVNEGLVDGW DDPRFPTVRG VLRRGMTVEG LKQFIAAQGS 480
SRSVVNMEWD KIWAFNKKVI DPVAPRYVAL LKKEVIPVNV PEAQEEMKEV AKHPKNPEVG 540
LKPVWYSPKV FIEGADAETF SEGEMVTFIN WGNLNITKIH KNADGKIISL DAKLNLENKD 600
YKKTTKVTWL AETTHALPIP VICVTYEHLI TKPVLGKDED FKQYVNKNSK HEELMLGDPC 660
LKDLKKGDII QLQRRGFFIC DQPYEPVSPY SCKEAPCVLI YIPDGHTKEM PTSGSKEKTK 720
VEATKNETSA PFKERPTPSL NNNCTTSEDS LVLYNRVAVQ GDVVRELKAK KAPKEDVDAA 780
VKQLLSLKAE YKEKTGQEYK PGNPPAEIGQ NISSNSSASI LESKSLYDEV AAQGEVVRKL 840
KAEKSPKAKI NEAVECLLSL KAQYKEKTGK EYIPGQPPLS QSSDSSPTRN SEPAGLETPE 900
AKVLFDKVAS QGEVVRKLKT EKAPKDQVDI AVQELLQLKA QYKSLIGVEY KPVSATGAED 960
KDKKKKEKEN KSEKQNKPQK QNDGQRKDPS KNQGGGLSSS GAGEGQGPKK QTRLGLEAKK 1020
EENLADWYSQ VITKSEMIEY HDISGCYILR PWAYAIWEAI KDFFDAEIKK LGVENCYFPM 1080
FVSQSALEKE KTHVADFAPE VAWVTRSGKT ELAEPIAIRP TSETVMYPAY AKWVQSHRDL 1140
PIKLNQWCNV VRWEFKHPQP FLRTREFLWQ EGHSAFATME EAAEEVLQIL DLYAQVYEEL 1200
LAIPVVKGRK TEKEKFAGGD YTTTIEAFIS ASGRAIQGGT SHHLGQNFSK MFEIVFEDPK 1260
IPGEKQFAYQ NSWGLTTRTI GVMTMVHGDN MGLVLPPRVA CVQVVIIPCG ITNALSEEDK 1320
EALIAKCNDY RRRLLSVNIR VRADLRDNYS PGWKFNHWEL KGVPIRLEVG PRDMKSCQFV 1380
AVRRDTGEKL TVAENEAETK LQAILEDIQV TLFTRASEDL KTHMVVANTM EDFQKILDSG 1440
KIVQIPFCGE IDCEDWIKKT TARDQDLEPG APSMGAKSLC IPFKPLCELQ PGAKCVCGKN 1500
PAKYYTLFGR SY 1512 
Gene Ontology
 GO:0005829; C:cytosol; TAS:Reactome.
 GO:0030529; C:ribonucleoprotein complex; IDA:UniProtKB.
 GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
 GO:0004818; F:glutamate-tRNA ligase activity; TAS:Reactome.
 GO:0004827; F:proline-tRNA ligase activity; TAS:Reactome.
 GO:0035613; F:RNA stem-loop binding; IDA:UniProtKB.
 GO:0071346; P:cellular response to interferon-gamma; IDA:UniProtKB.
 GO:0006424; P:glutamyl-tRNA aminoacylation; IEA:InterPro.
 GO:0017148; P:negative regulation of translation; IDA:UniProtKB.
 GO:0006433; P:prolyl-tRNA aminoacylation; IEA:InterPro.
 GO:0006461; P:protein complex assembly; TAS:ProtInc.
 GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome. 
Interpro
 IPR002314; aa-tRNA-synt_IIb_cons-dom.
 IPR001412; aa-tRNA-synth_I_CS.
 IPR006195; aa-tRNA-synth_II.
 IPR004154; Anticodon-bd.
 IPR004526; Glu-tRNA-synth_Ib_arc/euk.
 IPR000924; Glu/Gln-tRNA-synth_Ib.
 IPR020061; Glu/Gln-tRNA-synth_Ib_a-bdl.
 IPR020058; Glu/Gln-tRNA-synth_Ib_cat-dom.
 IPR020059; Glu/Gln-tRNA-synth_Ib_codon-bd.
 IPR010987; Glutathione-S-Trfase_C-like.
 IPR004499; Pro-tRNA-ligase_IIa_arc-type.
 IPR016061; Pro-tRNA_ligase_II_C.
 IPR017449; Pro-tRNA_synth_II.
 IPR020056; Rbsml_L25/Gln-tRNA_synth_b-brl.
 IPR011035; Ribosomal_L25/Gln-tRNA_synth.
 IPR014729; Rossmann-like_a/b/a_fold.
 IPR009068; S15_NS1_RNA-bd.
 IPR000738; WHEP-TRS. 
Pfam
 PF03129; HGTP_anticodon
 PF09180; ProRS-C_1
 PF00749; tRNA-synt_1c
 PF03950; tRNA-synt_1c_C
 PF00587; tRNA-synt_2b
 PF00458; WHEP-TRS 
SMART
 SM00946; ProRS-C_1
 SM00991; WHEP-TRS 
PROSITE
 PS00178; AA_TRNA_LIGASE_I
 PS50862; AA_TRNA_LIGASE_II
 PS00762; WHEP_TRS_1
 PS51185; WHEP_TRS_2 
PRINTS
 PR00987; TRNASYNTHGLU.